Zymeworks, Inc. (ZYME)
26.12
-0.74
(-2.76%)
USD |
NASDAQ |
Nov 20, 16:00
26.12
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Gross Profit (TTM) : 256.94M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 256.94M |
| June 30, 2026 | 28.05M |
| March 31, 2026 | 70.93M |
| December 31, 2025 | 95.17M |
| September 30, 2025 | 121.69M |
| June 30, 2025 | 110.00M |
| March 31, 2025 | 81.20M |
| December 31, 2024 | 65.11M |
| September 30, 2024 | 51.35M |
| June 30, 2024 | 47.98M |
| March 31, 2024 | 33.75M |
| December 31, 2023 | 58.71M |
| September 30, 2023 | 445.31M |
| June 30, 2023 | 435.35M |
| March 31, 2023 | 432.86M |
| December 31, 2022 | 400.18M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| AbbVie, Inc. | 48.66B |
| Faeth Therapeutics, Inc. | -0.106M |
| ACADIA Pharmaceuticals, Inc. | 1.088B |
| Alnylam Pharmaceuticals, Inc. | 3.874B |
| Anika Therapeutics, Inc. | 78.26M |